Assignee
VEROSCIENCE LLC
US·32 granted patents·17 pending applications·341 citations·filing 2008–2025
Top patents by PatentIndex Score
49 records- 0199US11560375B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2020·Granted Jan 24, 2023·6 cites·32 claims
- 0299US11241429B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2020·Granted Feb 8, 2022·10 cites·23 claims
- 0398US11883399B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2022·Granted Jan 30, 2024·5 cites·21 claims
- 0498US11607455B2Method for inducing tumor regressionVEROSCIENCE LLC·Filed 2020·Granted Mar 21, 2023·6 cites·20 claims
- 0598US11000522B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2020·Granted May 11, 2021·10 cites·24 claims
- 0698US10675282B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2019·Granted Jun 9, 2020·11 cites·18 claims
- 0797US11878974B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2021·Granted Jan 23, 2024·4 cites·31 claims
- 0897US10688094B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2019·Granted Jun 23, 2020·11 cites·30 claims
- 0997US9352025B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2014·Granted May 31, 2016·21 cites·19 claims
- 1097US2026062409A1Composition and Method for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2025·Application pending·0 cites
- 1196US11666567B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2021·Granted Jun 6, 2023·4 cites·22 claims
- 1296US11045464B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2016·Granted Jun 29, 2021·10 cites·21 claims
- 1396US10688155B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2018·Granted Jun 23, 2020·10 cites·57 claims
- 1496US9895422B2Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disordersVEROSCIENCE LLC·Filed 2016·Granted Feb 20, 2018·10 cites·19 claims
- 1596US9205084B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2013·Granted Dec 8, 2015·28 cites·17 claims
- 1696US9192576B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2013·Granted Nov 24, 2015·30 cites·54 claims
- 1795US10894791B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2017·Granted Jan 19, 2021·10 cites·12 claims
- 1895US10307421B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2018·Granted Jun 4, 2019·11 cites·25 claims
- 1995US10238653B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2017·Granted Mar 26, 2019·12 cites·10 claims
- 2095US9700555B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2016·Granted Jul 11, 2017·12 cites·100 claims
- 2194US9993474B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2017·Granted Jun 12, 2018·11 cites·51 claims
- 2294US9925186B2Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2015·Granted Mar 27, 2018·11 cites·15 claims
- 2394US9522117B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2015·Granted Dec 20, 2016·12 cites·61 claims
- 2494US8613947B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2013·Granted Dec 24, 2013·32 cites·30 claims
- 2593US9999653B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersVEROSCIENCE LLC·Filed 2016·Granted Jun 19, 2018·11 cites·11 claims
- 2692US11510921B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2018·Granted Nov 29, 2022·7 cites·12 claims
- 2791US9415005B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2013·Granted Aug 16, 2016·13 cites·21 claims
- 2891US9364515B2Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disordersVEROSCIENCE LLC·Filed 2014·Granted Jun 14, 2016·13 cites·12 claims
- 2989US10137132B2Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2014·Granted Nov 27, 2018·10 cites·10 claims
- 3087US2024131026A1Bromocriptine formulationsVEROSCIENCE LLC·Filed 2023·Application pending·0 cites
- 3186US12492198B2Composition and method for treating metabolic disordersVEROSCIENCE LLC·Filed 2022·Granted Dec 9, 2025·0 cites·11 claims
- 3286US12274698B2Bromocriptine formulationsVEROSCIENCE LLC·Filed 2023·Granted Apr 15, 2025·0 cites·16 claims
- 3385US2023286974A1Composition and Method for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2023·Application pending·0 cites
- 3484US12318451B2Method for inducing tumor regressionVEROSCIENCE LLC·Filed 2023·Granted Jun 3, 2025·0 cites·25 claims
- 3582US12357693B2Method for inducing tumor regressionVEROSCIENCE LLC·Filed 2022·Granted Jul 15, 2025·0 cites·20 claims
- 3680US2025269029A1Method for inducing tumor regressionVEROSCIENCE LLC·Filed 2025·Application pending·0 cites
- 3777US2025275961A1Bromocriptine formulationsVEROSCIENCE LLC·Filed 2025·Application pending·0 cites
- 3870US2022142960A1Compositions and Methods for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 3967US2009137598A1Method of treating metabolic disorders and depression with dopamine receptor agonistsVEROSCIENCE LLC·Filed 2008·Application pending·0 cites
- 4066US2025375406A1Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver diseaseVEROSCIENCE LLC·Filed 2023·Application pending·0 cites
- 4166US2019160059A1Compositions and Methods for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2018·Application pending·0 cites
- 4265US2022125379A1Methods for identifying responders to dopaminergic neuronal enhancing therapies for the treatment of elevated heart rate and metabolic or cardiovascular conditionsVEROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 4364US2010035886A1Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2009·Application pending·0 cites
- 4464US2017305898A1Composition and Method for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2017·Application pending·0 cites
- 4558US2015011554A1Compositions and Methods for Treating Metabolic DisordersVEROSCIENCE LLC·Filed 2014·Application pending·0 cites
- 4657US2017340271A1Methods for identifying responders to dopaminergic neuronal enhancing therapies for the treatment of elevated heart rate and metabolic or cardiovascular conditionsVEROSCIENCE LLC·Filed 2017·Application pending·0 cites
- 4757US2021401824A1Parenteral Formulations of Dopamine AgonistsVEROSCIENCE LLC·Filed 2021·Application pending·0 cites
- 4851US2018177874A1Methods of Treating Metabolic Syndrome Using Dopamine Receptor AgonistsVEROSCIENCE LLC·Filed 2018·Application pending·0 cites
- 4948US2017209539A1Therapeutic Treatment For Metabolic Syndrome, Type 2 Diabetes, Obesity, Or PrediabetesVEROSCIENCE LLC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →